Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Nuwellis (Nasdaq: NUWE), a medical technology company focused on fluid management solutions for critically ill patients, will participate in the upcoming Webull Financial Corporate Connect Webinar Series focused on Biotech/MedTech companies.
The virtual presentation will be delivered by John Erb, President and Chief Executive Officer, on Thursday, August 21, 2025 at 2:40 PM ET. The event is part of a broader virtual conference taking place from August 19-21, 2025.
Nuwellis (Nasdaq: NUWE), azienda di tecnologia medica specializzata in soluzioni per la gestione dei fluidi nei pazienti critici, parteciperà alla prossima serie di webinar Webull Financial Corporate Connect dedicata alle società Biotech/MedTech.
La presentazione virtuale sarà tenuta da John Erb, Presidente e Amministratore Delegato, giovedì 21 agosto 2025 alle 14:40 ET. L'evento fa parte di una conferenza virtuale più ampia che si svolgerà dal 19 al 21 agosto 2025.
Nuwellis (Nasdaq: NUWE), compañía de tecnología médica centrada en soluciones de manejo de fluidos para pacientes críticos, participará en la próxima serie de seminarios web Webull Financial Corporate Connect dedicada a empresas Biotech/MedTech.
La presentación virtual será impartida por John Erb, Presidente y Director Ejecutivo, el jueves 21 de agosto de 2025 a las 2:40 PM ET. El evento forma parte de una conferencia virtual más amplia que se celebrará del 19 al 21 de agosto de 2025.
Nuwellis (나스닥: NUWE)는 중증 환자의 체액 관리 솔루션에 주력하는 의료기술 회사로, 바이오테크/메드텍 기업을 대상으로 하는 Webull Financial Corporate Connect 웨비나 시리즈에 참여합니다.
가상 발표는 존 얼브(John Erb) 사장 겸 최고경영자가 2025년 8월 21일 목요일 동부시각 오후 2시 40분(ET)에 진행합니다. 해당 행사는 2025년 8월 19일부터 21일까지 열리는 더 큰 가상 컨퍼런스의 일부입니다.
Nuwellis (Nasdaq: NUWE), société de technologie médicale spécialisée dans les solutions de gestion des fluides pour les patients en état critique, participera à la prochaine série de webinaires Webull Financial Corporate Connect dédiée aux entreprises Biotech/MedTech.
La présentation virtuelle sera assurée par John Erb, Président et Directeur Général, le jeudi 21 août 2025 à 14h40 ET. Cet événement s'inscrit dans une conférence virtuelle plus large qui se tiendra du 19 au 21 août 2025.
Nuwellis (Nasdaq: NUWE), ein Medizintechnikunternehmen, das sich auf Flüssigkeitsmanagementlösungen für kritisch kranke Patienten spezialisiert hat, wird an der kommenden Webull Financial Corporate Connect Webinar-Reihe teilnehmen, die sich an Biotech-/MedTech-Unternehmen richtet.
Die virtuelle Präsentation hält John Erb, Präsident und Chief Executive Officer, am Donnerstag, den 21. August 2025 um 14:40 Uhr ET. Die Veranstaltung ist Teil einer größeren virtuellen Konferenz, die vom 19. bis 21. August 2025 stattfindet.
- None.
- None.
Live video webcast on Thursday, August 21st at 2:40 PM ET
MINNEAPOLIS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025.
Details for the presentation are as follows:
Date/Time: Thursday, August 21, 2025 at 2:40 PM ET
Presenter: John Erb, President and Chief Executive Officer
Registration Link: HERE
About Webull Financial
Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of assets, advanced charting tools, and real-time market data, Webull is revolutionizing the way individuals approach investing. The user-centric approach and commitment to staying at the forefront of industry trends underscore the mission to provide a seamless and rewarding experience for traders of all levels. Through the Webull Group, Webull Financial and its affiliates combine to serve tens of millions of users from over 180 countries worldwide. Securities and futures trading is offered to customers by Webull Financial LLC ("Webull Financial"), a broker-dealer registered with the Securities and Exchange Commission (SEC) and a futures commission merchant registered with the Commodity Futures Trading Commission (CFTC). Webull Financial is a member of the Financial Industry Authority (FINRA), the National Futures Association (NFA), and the Securities Investor Protection Corporation (SIPC). All investing is subject to risk, including the possible loss of principal. For more information about Webull, visit www.webull.com.
About Nuwellis
Nuwellis, Inc. (Nasdaq: NUWE) is a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, with a wholly owned subsidiary in Ireland. For more information visit www.nuwellis.com or visit us on LinkedIn or X, formerly known as Twitter.
For further information, please contact:
Investor Contact:
JTC Team, LLC
Jenene Thomas
(908) 824-0775
nuwe@jtcir.com
Media Contact:
Leah McMullen
Director of Communications
Leah.mcmullen@nuwellis.com
FAQ
When is Nuwellis (NUWE) presenting at the Webull Financial Corporate Connect Webinar Series?
Who will be presenting for Nuwellis (NUWE) at the Webull Financial Webinar?
What does Nuwellis (NUWE) specialize in?
How can investors access the Nuwellis (NUWE) Webull Financial presentation?
